HB 1624 (see companion bill SB 1520) – Texas

Status: Enacted
Year Introduced: 2015
Link: https://legiscan.com/TX/text/HB1624/id/1240742/Texas-2015-HB1624-Enrolled.html

TRANSPARENCY RELATED TO CERTAIN HEALTH BENEFIT PLAN COVERAGE – HEALTHCARE PROVIDER DIRECTORIES: requires health benefit plan issuers to display formulary information, via a direct and conspicuous electronic link, on the issuer’s Internet website. The formulary disclosures must include, for each drug the cost-sharing amount, including: (i) the dollar amount of a copayment; or (ii) for a drug subject to coinsurance, the cost-sharing range (e.g., “under $100 – $;” $100-250 – $,” etc.). The formulary disclosures must also identify prior authorizations, step therapies, other protocol requirements, tier the drug is in (if a tier-based system), whether drug is included in plan deductible or not and how so, preferred formulary drugs, and an explanation of coverage for each formulary drug.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found